>>Bad news for patients and some investors, possible good news for imetelstat (Geron) and some investors.<<
Good news for imetelstat??? Why should one drug failing be good news for another drug failing? Do you know how many years imetelstat (GRN163L) has been in clinical trials? (Almost 5.) How many clinical trials have been run or are running with that drug? How many types of cancer they have looked at?